Smell as a Disease Marker in Multiple Sclerosis
Existing data suggest that people with multiple sclerosis (pwMS) are at an elevated risk for experiencing olfactory impairment. We investigated if smell dysfunction can be used as an MS disease marker. This is a cross-sectional, case–control study. All data were collected prospectively from 171 part...
Main Authors: | Athanasia Printza, Marina Boziki, Constantinos Valsamidis, Christos Bakirtzis, Jannis Constantinidis, Nikolaos Grigoriadis, Stefanos Triaridis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/17/5215 |
Similar Items
-
Smell and Taste Loss Recovery Time in COVID-19 Patients and Disease Severity
by: Athanasia Printza, et al.
Published: (2021-03-01) -
Clinical factors influencing olfactory performance in patients with persistent COVID‐19 smell loss longer than 1 year
by: Alfonso Luca Pendolino, et al.
Published: (2023-12-01) -
Spanish Validation for Olfactory Function Testing Using the Sniffin’ Sticks Olfactory Test: Threshold, Discrimination, and Identification
by: María Luisa Delgado-Losada, et al.
Published: (2020-12-01) -
Objective smells and partial perspectives
by: Giulia Martina
Published: (2021-12-01) -
Correlation and agreement of olfactory perception assessed by the Connecticut Chemosensory Clinical Research Center olfactory test and the Brief-Smell Identification Test
by: Marcello Bailarini Aniteli, et al.
Published: (2022-11-01)